美通社

2025-11-05 13:42

KLN Appointed by Ego Pharmaceuticals as 4PL Partner in Hong Kong Strategic Collaboration to Deliver End-to-End Healthcare Supply Chain Solutions

HONG KONG, Nov. 5, 2025 /PRNewswire/ -- KLN Logistics Group Limited ('KLN'; Stock Code 0636.HK) is pleased to announce the appointment of its pharmaceutical arm, KLN Pharma (Hong Kong) Limited ('KLN Pharma'), as the fourth-party logistics (4PL) service provider for Australian skincare brand Ego Pharmaceuticals in Hong Kong. Under the partnership, KLN Pharma will manage Ego Pharmaceuticals' entire supply chain operations across a wide range of skincare and pharmaceutical products.

KLN Pharma will oversee domestic distribution to Ego Pharmaceuticals' retail outlets, pharmacies, drugstores and key chain channels. It will also utilise its GMP-compliant infrastructure, multi-temperature storage capabilities and proprietary inventory systems to ensure product integrity and regulatory compliance from inbound logistics, inventory management to distribution. The partnership encompasses marketing logistics support, enabling Ego Pharmaceuticals to accelerate product launches and promotional campaigns in Hong Kong's competitive skincare and healthcare landscape.

Samuel Lau, Managing Director - Integrated Logistics of KLN, said, "We are thrilled to partner with Ego Pharmaceuticals, a company that exemplifies scientific excellence and sustainable innovation. Our 4PL model offers the agility, compliance and scalability needed to support Ego's growth ambitions in Hong Kong."

Ted Pitts, Global Supply Chain Manager of Ego Pharmaceuticals, said, "We are committed to delivering science-backed skincare solutions to consumers across Asia. KLN's logistics expertise and deep understanding of pharmaceutical distribution make them an ideal partner for our Hong Kong operations."

KLN Pharma, has grown rapidly in recent years. The company's self-owned warehouses, advanced digital platforms and dedicated healthcare logistics team provide a strong foundation for managing complex supply chains in regulated environments. With pharmaceutical logistics projected to reach US$173 billion globally by 2030*, KLN is well-positioned to play a pivotal role in delivering integrated, consumer-centric supply chain solutions.

*Source: Pharmaceutical Logistics Market Size & Share Analysis - Trends, Drivers, Competitive Landscape, and Forecasts (2024-2030) by Prescient & Strategic Intelligence

About KLN Logistics Group Limited (Stock Code 0636.HK)

KLN (formerly known as Kerry Logistics Network Limited) is an Asia-based, global 3PL with a highly diversified business portfolio and extensive coverage in Asia. It offers a broad range of supply chain solutions from integrated logistics, international freight forwarding (air, ocean, road, rail and multimodal) and e-commerce to industrial project logistics and infrastructure investment.

With a global presence across 58 countries and territories, KLN has established a solid foothold in half of the world's emerging markets. Its diverse infrastructure, extensive coverage in international gateways and local expertise span across the Chinese Mainland, India, Southeast Asia, the CIS, Middle East, LATAM and other locations.

KLN generated a revenue* of close to HK$60 billion in 2024. It is listed on the Hong Kong Stock Exchange and is a constituent of the Hang Seng Corporate Sustainability Benchmark Index.

* For continuing operations only

About KLN Pharma (Hong Kong) Limited

KLN Pharma is a leading fourth-party logistics (4PL) provider specialising in the pharmaceutical and healthcare sectors. Leveraging an integrated service model, the company offers end-to-end supply chain solutions from GDP-compliant warehousing and cold chain distribution to regulatory support and a range of value-added services. KLN Pharma ensures regulatory compliance, operational efficiency and reliable delivery across the entire pharmaceutical supply chain.

About Ego Pharmaceuticals

Ego Pharmaceuticals is an Australian-owned company that specialises in the research, development, and marketing of innovative skincare products. With a focus on quality and efficacy, Ego Pharmaceuticals is committed to meeting the diverse needs of healthcare professionals and consumers. For more information, visit www.egopharm.com

source: KLN Logistics Group Limited

【你點睇?】港交所推每周股票期權新選擇,若能新增一隻作每周股票期權標的,您會選擇哪一隻?► 立即讚好

人氣文章
財經新聞
評論
專題
專業版
HV2
精裝版
SV2
串流版
IQ 登入
強化版
TQ
強化版
MQ

etnet初心不變 風雨無阻 與你並肩投資路,立即加入成為etnet YouTube頻道會員!

獨家優惠【etnet x 環球海產】 用戶專享全場95折,特價貨品更可折上折,立即選購五星級酒店御用海鮮!

樂本健 x etnet健康網購 | 購物滿額即送免費禮品

大國博弈

貨幣攻略

關稅戰

說說心理話

Watch Trends 2025

北上食買玩

Wonder in Art

理財秘笈

山今養生智慧

輕鬆護老

照顧者 情緒健康